A citation-based method for searching scientific literature

Vito Di Lernia, Mohamad Goldust. Expert Opin Biol Ther 2018
Times Cited: 17







List of co-cited articles
65 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Efficacy and Safety of Secukinumab in Elderly Subjects with Moderate to Severe Plaque Psoriasis: A Pooled Analysis of Phase III Studies.
Andreas Körber, Charis Papavassilis, Vaishali Bhosekar, Maximilian Reinhardt. Drugs Aging 2018
31
58

Efficacy and safety of systemic treatments for psoriasis in elderly patients.
Stefano Piaserico, Andrea Conti, Francesco Lo Console, Clara De Simone, Francesca Prestinari, Annamaria Mazzotta, Giulio Gualdi, Claudio Guarneri, Stefania Borsari, Nicoletta Cassano. Acta Derm Venereol 2014
57
47

Efficacy and safety of ustekinumab treatment in elderly patients with psoriasis.
Mitsuha Hayashi, Yoshinori Umezawa, Osamu Fukuchi, Toshihiro Ito, Hidehisa Saeki, Hidemi Nakagawa. J Dermatol 2014
47
41

Managing moderate-to-severe psoriasis in the elderly.
Nicola Balato, Cataldo Patruno, Maddalena Napolitano, Angela Patrì, Fabio Ayala, Raffaele Scarpa. Drugs Aging 2014
39
41

Elderly psoriatic patients under biological therapies: an Italian experience.
F Ricceri, F Bardazzi, A Chiricozzi, P Dapavo, F Ferrara, C Mugheddu, M Romanelli, F Rongioletti, F Prignano. J Eur Acad Dermatol Venereol 2019
17
41

Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM] 1).
Kim Papp, Kristian Reich, Craig L Leonardi, Leon Kircik, Sergio Chimenti, Richard G B Langley, ChiaChi Hu, Randall M Stevens, Robert M Day, Kenneth B Gordon,[...]. J Am Acad Dermatol 2015
323
35

Biologic Treatment in Elderly Patients With Psoriasis: A Systematic Review.
Vijay Kumari Sandhu, Arvin Ighani, Patrick Fleming, Charles W Lynde. J Cutan Med Surg 2020
13
46

Efficacy and safety of subcutaneous anti-tumor necrosis factor-alpha agents, etanercept and adalimumab, in elderly patients affected by psoriasis and psoriatic arthritis: an observational long-term study.
Maria Esposito, Alessandro Giunta, Annamaria Mazzotta, Arianna Zangrilli, Graziella Babino, Mauro Bavetta, Roberto Perricone, Sergio Chimenti, Maria Sole Chimenti. Dermatology 2012
54
29

Efficacy and safety of ustekinumab in a group of 22 elderly patients with psoriasis over a 2-year period.
M Megna, M Napolitano, N Balato, G Monfrecola, A Villani, F Ayala, A Balato. Clin Exp Dermatol 2016
30
29


Psoriasis in the elderly: from the Medical Board of the National Psoriasis Foundation.
Ivan S Grozdev, Abby S Van Voorhees, Alice B Gottlieb, Sylvia Hsu, Mark G Lebwohl, Bruce F Bebo, Neil J Korman. J Am Acad Dermatol 2011
36
29


Biologic treatments for elderly patients with psoriasis.
Mami Momose, Akihiko Asahina, Mitsuha Hayashi, Koichi Yanaba, Yoshinori Umezawa, Hidemi Nakagawa. J Dermatol 2017
22
23

Efficacy and safety of adalimumab across subgroups of patients with moderate to severe psoriasis.
Alan Menter, Kenneth B Gordon, Craig L Leonardi, Yihua Gu, Orin M Goldblum. J Am Acad Dermatol 2010
107
23

Etanercept for the treatment of psoriasis in the elderly.
Giuseppe Militello, Amy Xia, Seth R Stevens, Abby S Van Voorhees. J Am Acad Dermatol 2006
31
23

Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trials.
Kristian Reich, Kim A Papp, Andrew Blauvelt, Stephen K Tyring, Rodney Sinclair, Diamant Thaçi, Kristine Nograles, Anish Mehta, Nicole Cichanowitz, Qing Li,[...]. Lancet 2017
280
23

Long-term safety and tolerability of apremilast in patients with psoriasis: Pooled safety analysis for ≥156 weeks from 2 phase 3, randomized, controlled trials (ESTEEM 1 and 2).
Jeffrey Crowley, Diamant Thaçi, Pascal Joly, Ketty Peris, Kim A Papp, Joana Goncalves, Robert M Day, Rongdean Chen, Kamal Shah, Carlos Ferrándiz,[...]. J Am Acad Dermatol 2017
95
23

Efficacy and safety of infliximab in psoriatic patients over the age of 65.
Andrea Chiricozzi, Athanasios Pavlidis, Annunziata Dattola, Luca Bianchi, Maria Sole Chimenti, Monika Fida, Rosita Saraceno. Expert Opin Drug Saf 2016
16
25

Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials.
Kenneth B Gordon, Bruce Strober, Mark Lebwohl, Matthias Augustin, Andrew Blauvelt, Yves Poulin, Kim A Papp, Howard Sofen, Lluís Puig, Peter Foley,[...]. Lancet 2018
264
23


Safety concerns with current treatments for psoriasis in the elderly.
Roberta Di Caprio, Giuseppina Caiazzo, Sara Cacciapuoti, Gabriella Fabbrocini, Emanuele Scala, Anna Balato. Expert Opin Drug Saf 2020
10
40

Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis.
Mark Lebwohl, Bruce Strober, Alan Menter, Kenneth Gordon, Jolanta Weglowska, Lluis Puig, Kim Papp, Lynda Spelman, Darryl Toth, Francisco Kerdel,[...]. N Engl J Med 2015
487
17

A prospective phase III, randomized, double-blind, placebo-controlled study of brodalumab in patients with moderate-to-severe plaque psoriasis.
K A Papp, K Reich, C Paul, A Blauvelt, W Baran, C Bolduc, D Toth, R G Langley, J Cather, A B Gottlieb,[...]. Br J Dermatol 2016
281
17

Psychiatric adverse events during treatment with brodalumab: Analysis of psoriasis clinical trials.
Mark G Lebwohl, Kim A Papp, Lauren B Marangell, John Koo, Andrew Blauvelt, Melinda Gooderham, Jashin J Wu, Shipra Rastogi, Susan Harris, Radhakrishnan Pillai,[...]. J Am Acad Dermatol 2018
83
17


Safety of classic and biologic systemic therapies for the treatment of psoriasis in elderly: an observational study from national BIOBADADERM registry.
C Medina, G Carretero, C Ferrandiz, E Dauden, F Vanaclocha, F J Gómez-García, E Herrera-Ceballos, P De la Cueva-Dobao, I Belinchón, J L Sánchez-Carazo,[...]. J Eur Acad Dermatol Venereol 2015
34
17


Advances in treating psoriasis in the elderly with small molecule inhibitors.
Abigail Cline, Leah A Cardwell, Steven R Feldman. Expert Opin Pharmacother 2017
8
37


Safety of selective IL-23p19 inhibitors for the treatment of psoriasis.
J J Crowley, R B Warren, J C Cather. J Eur Acad Dermatol Venereol 2019
37
17



Efficacy and safety of ixekizumab in a group of 16 elderly patients with psoriasis over a 1-year period.
M Megna, E Cinelli, A Balato, L Gallo, G Fabbrocini. J Eur Acad Dermatol Venereol 2020
9
33

European S3-Guideline on the systemic treatment of psoriasis vulgaris - Update Apremilast and Secukinumab - EDF in cooperation with EADV and IPC.
A Nast, P I Spuls, G van der Kraaij, P Gisondi, C Paul, A D Ormerod, P Saiag, C H Smith, E Dauden, E M de Jong,[...]. J Eur Acad Dermatol Venereol 2017
81
17

Keratinocyte overexpression of IL-17C promotes psoriasiform skin inflammation.
Andrew Johnston, Yi Fritz, Sean M Dawes, Doina Diaconu, Paul M Al-Attar, Andrew M Guzman, Cynthia S Chen, Wen Fu, Johann E Gudjonsson, Thomas S McCormick,[...]. J Immunol 2013
184
11

The role of IL-17 in psoriasis.
Mona Malakouti, Gabrielle Elena Brown, Eva Wang, John Koo, Ethan C Levin. J Dermatolog Treat 2015
41
11




Psoriatic disease treatment nowadays: unmet needs among the "jungle of biologic drugs and small molecules".
Matteo Megna, Anna Balato, Maddalena Napolitano, Lucia Gallo, Francesco Caso, Luisa Costa, Nicola Balato, Raffaele Scarpa. Clin Rheumatol 2018
31
11


The safety of anti-TNF agents in the elderly.
A Migliore, E Bizzi, B Laganà, L Altomonte, G Zaccari, M Granata, M Canzoni, B Marasini, M Massarotti, U Massafra,[...]. Int J Immunopathol Pharmacol 2009
27
11

Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis: a multinational, double-blind, randomized, placebo-controlled clinical trial.
J Peter Kaltwasser, Peter Nash, Dafna Gladman, Cheryl F Rosen, Frank Behrens, Peter Jones, Jürgen Wollenhaupt, Franziska G Falk, Philip Mease. Arthritis Rheum 2004
279
11

Psoriasis in elderly and non-elderly population: clinical and molecular features.
Maddalena Napolitano, Nicola Balato, Fabio Ayala, Cataldo Patruno, Angela Patrì, Matteo Megna, Anna Balato. G Ital Dermatol Venereol 2016
13
15

A clinical review of phototherapy for psoriasis.
Ping Zhang, Mei X Wu. Lasers Med Sci 2018
89
11

Quality of life impairment and psychological distress in elderly patients with psoriasis.
F Sampogna, S Tabolli, S Mastroeni, C Di Pietro, C Fortes, D Abeni. Dermatology 2007
30
11

Geriatric inflammatory bowel disease: phenotypic presentation, treatment patterns, nutritional status, outcomes, and comorbidity.
Manie Juneja, Leonard Baidoo, Marc B Schwartz, Arthur Barrie, Miguel Regueiro, Michael Dunn, David G Binion. Dig Dis Sci 2012
101
11

Biologic and Conventional Systemic Therapies Show Similar Safety and Efficacy in Elderly and Adult Patients With Moderate to Severe Psoriasis.
Caren Garber, Natalia Plotnikova, Shiu-chung Au, Eric P Sorensen, Alice Gottlieb. J Drugs Dermatol 2015
22
11

Long-term continuous versus intermittent cyclosporin: therapy for psoriasis.
Mamitaro Ohtsuki, Hidemi Nakagawa, Junichi Sugai, Akira Ozawa, Muneo Ohkido, Juichiro Nakayama, Jiro Hanada, Yosuke Morimoto, Kowichi Jimbow, Takashi Horikoshi,[...]. J Dermatol 2003
27
11



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.